Figure 3.
Differences in the proportions of B lymphocyte maturation between the CVID with complicated phenotype (CVID-C) group, CVID phenotype limited to only infections (CVID-OI group), patients with systemic lupus erythematosus (SLE), and healthy controls (HCs). Data expressed as median (Q1–Q3), * p < 0.05.
